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Functional Imaging and 
Physiological Modulation with 
Acupuncture in Parkinson’s 
Disease and Nonhuman Primate 
Models of Dopamine Dysfunction
Yi-Ning Yin, Jorge E. Quintero and Zhiming M. Zhang
Abstract
Here we review functional imaging and neurophysiological evidence for the pre-
clinical and clinical use of electroacupuncture, a non-pharmaceutical-based thera-
peutic strategy, to relieve parkinsonian symptoms. Outcomes from those studies 
provide evidence that the effect of electroacupuncture can be objectively measured 
in nonhuman primate models of Parkinson’s disease and in patients with Parkinson’s 
disease. In addition, the evidence continues to support that electroacupuncture 
can be used in preclinical and clinical studies simply, safely, and effectively as an 
alternative and complementary treatment for disorders in Parkinson’s disease.
Keywords: acupuncture, pharmacological MRI, glutamate, cortex,  
electrochemistry
1. Introduction
Acupuncture has been gaining popularity for treatment of various disorders as 
an alternative therapy and has been used for years as treatment for a wide range of 
ailments from lower back pain to stroke to osteoarthritis to Parkinson’s disease (PD) 
[1–5]. Classical acupuncture is based on 14 mapped main channels on the body with 
about 365 acupoints distributed on the channels (meridian system); the flow of 
Qi (the vital life force or “energy”) maintains the balance and harmony of Yin and 
Yang. Any blockage of these channels or abnormal movement of Qi will result in ill-
ness, and acupuncture, by stimulating these acupoints along the meridian channels 
with needles, helps to restore movement of the Qi and Qi homeostasis (De Qi), thus 
modulating the autonomic nervous system and relieving the symptoms of various 
illnesses [6, 7]. The underlying mechanism of acupuncture has been under intense 
investigation and many theories have been discussed in the scientific community. 
For example, connective tissues or perivascular space with decreased electrical 
impedance and increased electrical conductivity have been suggested to constitute 
the meridian channels with acupoints along the pathway [7, 8]. Nevertheless, the 
efficacy of acupuncture remains largely unclear because of a skeptical attitude of 
how acupuncture works (especially within the framework of Western Medicine), 
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methodological flaws, and an absence of rigorous studies using objective outcome 
measures [1]. To date, the clinical outcomes of acupuncture are assessed by empiri-
cal observations rather than by objective, quality analysis [1, 3, 5].
Recent, rapid advances in technology, especially the use of functional magnetic 
resonance imaging (fMRI) to map global and/or target-specific bran regions, 
have shown great promise and could be extremely helpful for acupuncture 
studies in human subjects when combined with subjective measurements [8]. 
Pharmacological MRI (phMRI), a new application of fMRI, is using fMRI methods 
to map drug-induced activations inside the brain [9]. In this chapter, we discuss 
how phMRI can be used to map dopaminergic drug-induced changes in the brain 
before and after acupuncture treatment in parkinsonian monkeys. Similarly, fMRI 
methods have been used in the PD clinic. As an example, with acute acupuncture 
stimulations at GB34, analysis of fMRI signals showed activations in the putamen 
and the primary motor cortex, and these activations induced by acupuncture 
were correlated with patient self-reported improvements of finger-tapping [10]. 
Furthermore, phMRI has been used to monitor other treatments associated with 
PD in a preclinical, translational study [11]. The utility of fMRI/phMRI has even 
been extended to differentiate dysfunction in the basal ganglia between parkinso-
nian and aged monkeys [12]. Based on those clinical and preclinical studies, these 
imaging modalities have the possibility to help untangle the underlying neural 
mechanisms of acupuncture.
To date, few studies have been conducted in vivo to directly investigate the 
relationship between acute acupuncture stimulation and its effects on modulating 
neurotransmitters especially in large animals such as the rhesus macaque. In this 
chapter, to our knowledge, we would be the first to begin exploring whether acu-
puncture stimulation could suppress, or activate, cortical glutamate in normal and 
PD monkeys. In addition, we will also review fMRI and phMRI studies to provide 
some direct evidence demonstrating the relationship between acupuncture and 
neuronal activity and changes in neurotransmitter signaling in the CNS.
2. Evidence from neuroimaging studies
2.1 Functional/pharmacological MRI study in nonhuman primates
Over the past two decades, our group has been working to objectively and safely 
monitor anti-parkinsonian effects and brain activity modulated by electroacupunc-
ture (EA) in nonhuman primates modeling human PD. We maintained a group 
of late middle aged rhesus monkeys with long-term (>5 years) mild to moderate 
parkinsonism rendered by our standard procedures, unilateral administration of 
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [13]. This group of parkin-
sonian rhesus macaques was extensively evaluated by a computerized behavioral 
testing battery and by phMRI scans [14, 15]. First, stable parkinsonian features 
were observed in all animals before entering the EA study and all animals showed 
positive responses to a levodopa (l-dopa) challenge [14]. phMRI activation was 
then analyzed by our standard procedure. Briefly, while undergoing fMRI scans, 
animals received a subcutaneous injection of the dopamine agonist, apomorphine 
(APO). This pharmacological challenge then serves as the basis for assessing the 
changes in fMRI responses. Second, the phMRI results revealed that compared with 
the normal, pre-MPTP, status, APO-induced activations were found in all measured 
ROIs (Figure 1A and B, Table 1, described in [14]). The differences between nor-
mal and post-MPTP stages in response to the apomorphine challenge were signifi-
cant (P < 0.001), especially in the caudate nucleus, putamen, primary motor cortex 
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(M1), cingulate gyrus and globus pallidus externa (GPe). In contrast, blood oxygen 
level dependent (BOLD) responses in the pre-motor areas and the globus pallidus 
interna (GPi) were not significantly different (Table 1). These findings were in line 
with previous results [16] that APO-induced activations were seen in the striatum 
after animals became parkinsonian. In addition to those responses described above, 
APO-induced activations were also observed in the MPTP-lesioned primary motor 
cortex and cingulate gyrus (Figure 2 and Table 1).
The chronic EA treatment appeared to alter neuronal activities in some exam-
ined areas such as the caudate nucleus, putamen, primary motor cortex, cingulate 
gyrus and GPe in which strong APO-evoked activations were initially observed 
after MPTP lesions but then were significantly reduced after the EA treatment. In 
some cases, the BOLD activations nearly returned to the levels seen in the normal 
(pre-lesion) stage (Figure 1A and B and Table 1). However, the phMRI responses 
were relatively mild in the pre-motor cortex and GPi (Table 1). As shown in 
Figures 1 and 2, the most affected regions were the caudate nucleus and primary 
motor cortex. For example, the APO-induced activations were reduced more than 
5-fold in the caudate nucleus and 4-fold in the primary motor cortex. Interestingly, 
Figure 1. 
phMRI activation changes of animals following different treatments. phMRI activation changes of caudate 
nucleus (A) and putamen (B) following MPTP administration, chronic EA treatment or post EA treatment 
(from [14]).
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residual effects were observed 3 months after the last EA treatment in the caudate 
nucleus, putamen, primary motor cortex, and cingulate gyrus regions judged by 
comparing the values of BOLD-activations between MPTP + EA and MPTP + PEA 
(3 months post EA treatment). A significant difference (P < 0.05) between MPTP + 
EA and MPTP + PEA was also seen in the GPe (Table 1). The results strongly 
suggest that anti-parkinsonian effects of EA can be objectively assessed, and fMRI/
phMRI could be readily translated into the clinic with minor modifications.
Figure 2. 
phMRI activation changes of primary motor cortex following MPTP administration, chronic EA treatment or 
post EA treatment (adapted from [14]).
Cingulate GPe GPi
ROIs
Normal 0.74 ± 0.25 −0.27 ± 0.3 −0.16 ± 0.26
MPTP 2.16 ± 0.09a 1.92 ± 0.13a 0.84 ± 0.41
MPTP + EA 0.58 ± 0.23b 0.54 ± 0.19d,e 0.44 ± 0.31
MPTP + PEA 0.85 ± 0.11c 0.69 ± 0.09f 1.11 ± 0.14d
GPe, globus pallidus externa; GPi, globus pallidus interna; ROIs, region of interest; EA, electroacupuncture; PEA, 
post electroacupuncture (from [14]).
aP < 0.001 vs. normal.
bP < 0.001 vs. MPTP.
cP < 0.001 vs. MPTP + EA.
dP < 0.05 vs. normal.
eP < 0.01 vs. MPTP.
fP < 0.05 vs. MPTP + EA.
Table 1. 
BOLD-responses in some cortical and subcortical areas.
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2.2 Functional MRI studies in humans
In human studies, acupuncture stimulations that directly modulate brain 
activity can also be observed [17, 18]. An example of this was carried out by Li 
and colleagues [17] who used fMRI to investigate the potential neuromechanism 
of acupuncture on tremor in patients with Parkinson’s disease. Li and colleagues 
compared fMRI signals in patients with Parkinson’s disease who were either in the 
true acupuncture group (TAG) or the sham acupuncture group (SAG). Participants 
received levodopa for 12 weeks and received the study intervention twice weekly. 
Participants in TAG were acupunctured on DU20, GB20, and the Chorea-Tremor 
Controlled Zone. Participants in SAG were given sham acupuncture. fMRI scans of 
the participant’s brains were obtained before and after the 12-week period. As shown 
in Figure 3, acupuncture had specific effects on the activity of the cerebrocerebellar 
pathways as shown by a decrease in regional homogeneity (ReHo)—an indication 
of a decrease in local/regional activity. Other measures of brain activity, degree 
centrality (DC), and amplitude low-frequency fluctuation (ALFF) values, also 
showed decreases after acupuncture compared to sham. Meanwhile, increased ReHo 
values were observed within the thalamus and motor cortex [17]. The results of this 
clinical study demonstrate that functional imaging can directly detect and measure 
acupuncture-induced brain activities even at the level of the neural network.
In a separate clinic study to examine the underlying mechanisms of acupuncture in 
patients with major depressive disorders, Wang et al. [19] investigated the resting state 
functional connectivity (rsFC) in the left and right amygdala before and after verum 
acupuncture plus the antidepressant fluoxetine versus sham acupuncture plus fluoxetine. 
Resting-state fMRI data was collected before the first and last treatments. Participants 
received the study intervention for 8 weeks. Verum acupuncture treatment participants 
showed (1) greater clinical improvement than sham participants based on the depres-
sion rating scales; (2) increased rsFC between the left amygdala and subgenual anterior 
Figure 3. 
Differences in ReHo values between the TAG and SAG. (P < 0.05, AlphaSim corrected). Warm colors represent 
positive ReHo values; blue (cold) colors represent negative ReHo values (from [17]).
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cingulate cortex (sgACC)/pregenual anterior cingulate cortex (pgACC); (3) increased 
rsFC between the right amygdala and left parahippocampus/putamen. And finally, the 
strength of the amygdala-sgACC/pgACC rsFC was positively associated with a cor-
responding clinical improvement (Figure 4). Their findings show the additive effect of 
acupuncture to antidepressant treatment and suggest that this effect may be achieved 
through the limbic system, especially the amygdala and the ACC [19].
3. Evidence from electrochemical studies
In the brain, glutamatergic transmission plays a key role in the normal physiol-
ogy of those systems that modulate motor activity (especially in the basal ganglia). 
In Parkinson’s disease, glutamatergic transmission is considerably affected particu-
larly in the direct and indirect nigrostriatal pathways, which are known to involve 
glutamatergic hyperactivity. The glutamatergic hyperactive pattern, through a dual 
role, may exacerbate PD by first promoting excitotoxic events that contribute to the 
neurodegenerative process and, secondly, by contributing to the pathophysiology 
of dyskinesias and motor fluctuations that are associated with the chronic use of 
levodopa [20]. Since excitotoxicity is a glutamate-receptor-mediated phenomenon, 
growing interest and work have been dedicated to the research for modulators of 
glutamate neurotransmission that might enable new therapeutic interventions to 
slow the neurodegenerative process and ameliorate PD symptoms.
To explore the role of glutamate excitotoxicity in both acupuncture and patho-
genesis of PD, we designed a study to address the question of whether changes in 
cortical glutamate levels were one of the underlying mechanisms of EA (previously 
unpublished results). Based on human acupuncture studies in patients with PD, we 
trained two rhesus monkeys with mild but stable parkinsonian features (MPTP-
induced) including bradykinesia, rigidity on the affected upper and lower limbs. In 
addition, stooped posture and mild postural instability were also evident [13]. Then, 
these animals were treated with chronic (intermittent) EA treatments (3 session/
week/4 months) at acupoints ST 36, GB34, or LI 4 (Figure 5). Subsequently, they were 
also studied for behavioral changes by a non-biased, computerized testing battery. 
Results demonstrated that EA significantly improved motor functions measured 
by increased movement speed after a 4-month EA treatment (data now shown). 
Following the last EA treatment and behavioral tests, animals were anesthetized and 
resting levels of l-glutamate were measured in the primary motor areas (upper body) 
by enzyme-based biosensors [21] with acute EA stimulation at GV14 + EX-B9 or 
GV14 + ST 36 or LI 4 on both sides, or GV14 + non-acupoints (Figure 5). EA-induced 
Figure 4. 
Amygdala seed locations and brain regions with significant changes (post minus pre) of rsFC with the amygdala 
(a) modulated by the verum acupuncture plus fluoxetine compared with sham acupuncture plus fluoxetine 
treatment in the left sgACC/pgACC (b) and left Para/Pu (c). Abbreviations: sgACC, subgenual anterior 
cingulate cortex; pgACC, pregenual anterior cingulate cortex; Para, parahippocampus; Pu, putamen (from [19]).
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changes in cortical glutamate could be recorded in real time (2 Hz) with glutamate-
sensitive biosensors (Figure 6A). The EA treatments of GV14 + EX-B9, or GV14 + ST 
36 significantly decreased basal levels of glutamate in the primary motor cortex on 
the hemisphere contralateral to the MPTP-lesion immediately after the stimulator was 
turned on and returned to baseline levels after it was turned off. By contrast, stimula-
tion of GV14 and a non-acupuncture point produced no fluctuation in basal glutamate 
activity (Figure 6B). These results support the idea that EA can produce transient 
effects on cortical levels of glutamate that could be a means of providing a potential 
therapy for PD.
Acupuncture can alter extracellular glutamate as seen in our pilot nonhuman 
primate study and those results are supported by acupuncture studies in rodents. 
Lee et al. reported that acupuncture can attenuate extracellular glutamate levels in 
a global ischemia model in rat. In the study, the authors found that acupuncture at 
GB34 and GB39 significantly suppressed glutamate function compared to control 
animals [22]. Later, Kim et al. demonstrated that acupuncture at HT7 can inhibit 
methamphetamine-induced behaviors, dopamine release and hyperthermia in the 
nucleus accumbens through the group II metabotropic glutamate receptors [23].
Figure 5. 
Acupuncture points used in the study.
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4. Evidence from objective behavioral testing
4.1 Objective behavioral testing in preclinical studies
For years, our group has been developing testing methods to objectively measure 
behavioral changes before and after intermittent EA treatments in parkinsonian 
monkeys. Recently, we reported that EA-induced improvement of parkinsonism 
in rhesus macaques can be effectively measured using a non-biased, non-invasive 
and computerized behavioral testing battery [14]. The battery primarily includes 
a videotracking system to measure movement speed, an Actical accelerometer to 
monitor home-cage activity 24 h a day, 7 days a week, and an upper limb movement 
analysis panel to measure a subject retrieval time [14, 24]. As shown in Figure 7, 
significantly deceased movement speed (A), and home cage activity (B), and longer 
performance time of the affected hand (C) were found following MPTP admin-
istration. The movement speed and fine motor performance time were markedly 
Figure 6. 
(A) Real-time measurements of the basal glutamate change in the motor cortex with and without acupuncture 
stimulations. Glutamate changes in the unlesioned motor cortex produced by EA stimulation at GV14 + ST36 
(right side). Glutamate biosensors were used to measure glutamate levels. One biosensor recording site is 
coated with glutamate oxidase and capable of detecting glutamate a reference biosensor recording site lacking 
glutamate oxidase and incapable of detecting glutamate is used to subtract interfering agents. (B) Real-time 
measurement of the basal glutamate changes in the motor cortex with and without acupuncture stimulations. 
Glutamate changes in the unlesioned motor cortex produced by EA stimulation at GV14 + ST36 (right side) 
and GV14 + nonacupuncture points. TTL: transistor-transistor logic (event marker). GluOx+ (biosensor 
recording site coated with glutamate oxidase and capable of detecting glutamate), GluOx− (biosensor recording 
site lacking glutamate oxidase and incapable of detecting glutamate). Note the stimulation induced artifact 
in the reference channel (GluOx− recording site) during the course of stimulation that subsides when EA 
stimulation is terminated. Zoomed inset of Figure 6A.
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improved with chronic EA treatment (Figure 7A and C), and movement speed 
and fine motor performance times virtually returned to pre-MPTP levels. The cage 
activity was increased but did not reach statistically significant levels because of 
large variance (Figure 7B). Meanwhile, the fine motor performance time was still 
Figure 7. 
Behavior changes of animals following different treatments. Movement speed (A), home cage activity (B) 
and fine motor performance time changes (C) following MPTP administration, chronic EA treatment or post 
EA treatment (at least 1 months after last EA treatment). (a) P < 0.05 compared with normal; (b) P < 0.05 
compared with MPTP; (c) P < 0.05 compared with MPTP + EA (from [14]).
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improving one-month post EA treatment (Figure 7C). In addition, all animals 
responded positively to levodopa challenge evident by a 261% increase of home-cage 
activity measured via Actical counts.
4.2 Objective behavioral testing in clinical studies
In the acupuncture clinic, objective assessments using novel computerized 
technologies are drawing more attention. Lei and colleagues used body-worn sensor 
technology in patients with PD to measure a variety of gait parameters [3]. The 
authors found that EA improved gait function and achieved statistically significant 
improvements in gait speed under a variety of walking tasks including single-
task habitual walking, single-task fast walking, and dual-task fast walking. No 
significant changes were observed in the control group. Meanwhile, gait improve-
ments were correlated with the activities of daily living component of the Unified 
Parkinson’s Disease Rating Scale (UPDRS). This study further indicates that the 
effectiveness of EA treatment can be objectively measured and while still used with 
traditional instruments such as the UPDRS.
5. Summary
Current evidence shows that EA generates measurable changes in the brain that 
are detectable with functional imaging, behavioral responses, and neurotransmit-
ter signaling. The results from nonhuman primates also provides direct evidence 
between EA stimulations and dynamic alterations in the resting levels of glutamate 
in the motor cortex, which may at least partially explain a mechanism of action for 
EA in the nervous system. Nevertheless, we are only at beginning of a quest to bet-
ter understand the mechanism of action that underlie acupuncture. The few studies 
with limited number of subjects will have to expand if we are to understand how 
acupuncture affects the central nervous system.
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